Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Argus Health
Cantor Fitzgerald
Daiichi Sankyo
Moodys
Chubb
US Army
Baxter
Teva

Generated: June 19, 2018

DrugPatentWatch Database Preview

Hydrochlorothiazide; spironolactone - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; spironolactone and what is the scope of hydrochlorothiazide; spironolactone freedom to operate?

Hydrochlorothiazide; spironolactone
is the generic ingredient in three branded drugs marketed by Gd Searle Llc, Ascot, Mutual Pharm, Mylan, Purepac Pharm, Sun Pharm Industries, Superpharm, Watson Labs, Yaopharma Co Ltd, Ivax Pharms, Lederle, Parke Davis, Upsher Smith, Usl Pharma, and Vangard, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for hydrochlorothiazide; spironolactone. Six suppliers are listed for this compound.
Summary for hydrochlorothiazide; spironolactone
Pharmacology for hydrochlorothiazide; spironolactone
Ingredient-typeThiazides
Drug ClassAldosterone Antagonist
Thiazide Diuretic
Mechanism of ActionAldosterone Antagonists
Physiological EffectIncreased Diuresis
Synonyms for hydrochlorothiazide; spironolactone
C24H32O4S.C7H8ClN3O4S2
Hydrochlorothiazide / Spironolactone
LS-178649
MP 40 [Pill Imprint]
SCHEMBL930086
Spiridazide
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
Spironolactone-hydrochlorothiazide
Spironothiazid
Uractazide

US Patents and Regulatory Information for hydrochlorothiazide; spironolactone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087553-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Usl Pharma SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087651-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Purepac Pharm SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 088054-001 Aug 18, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mutual Pharm SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087267-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Deloitte
Johnson and Johnson
Express Scripts
Covington
Harvard Business School
Merck
Medtronic
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.